Manulife (Manufacturers Life Insurance)’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
AIA
GAI
VF
Manulife (Manufacturers Life Insurance)'s RPRX Position: Q3 2017 in Review
Manulife (Manufacturers Life Insurance) sold out of Repros Therapeutics Inc. (RPRX) in Q3 2017, closing a stake of 1,311 shares — an estimated $1K sold.
Manulife (Manufacturers Life Insurance) first reported a position in RPRX in Q2 2013 and held it in 17 quarters. The position peaked at $266K in Q2 2014. 28 funds tracked by Wall St. Rank hold RPRX as of Q3 2017.
- Manulife (Manufacturers Life Insurance) reported no remaining Repros Therapeutics Inc. position as of Q3 2017 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 1,311 Repros Therapeutics Inc. shares in Q3 2017, an estimated $1K.
- Manulife (Manufacturers Life Insurance) first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 17 quarters.
- Manulife (Manufacturers Life Insurance)'s Repros Therapeutics Inc. position peaked at $266K in Q2 2014.
- 28 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2017.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.